Fmr1-KO mice, a suitable tool to study core and secondary symptoms of autism spectrum disorders
Shirin Sharghi1,2, Stefanie Flunkert1, Magdalena Daurer1, Spyridon Sideromenos1, Boris Philippe Chagnaud2, Marcello Leopoldo3, Enza Lacivita3, Birgit Hutter-Paier1, and Manuela Prokesch1
1Department of Neuropharmacology, QPS Austria GmbH, Grambach, Austria, 2Institute for Biology, Karl-Franzens University of Graz, Graz, Austria, 3Department of Pharmacy, Drug Sciences, University of Bari, Bari, Italy